TS23 not checked

Translational Sciences, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
2 in total

What this is

How it works
How it works isn't classified yet
Tested for
Pulmonary Embolism, Ischemic Stroke
Main trialPhase 2
“Phase II trial of TS23”In the company’s words, NCT05408546 on ClinicalTrials.gov

Other drugs for Pulmonary Embolism

All 6 drugs for Pulmonary Embolism

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting 31 Aug 2026 Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Phase 2Recruiting Jul 2028 Strategy for Improving Stroke Treatment Response
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow TS23

Following is part of Solo: you see every change to TS23 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in